Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
The Product is expected to be the first generic approval on the market
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Subscribe To Our Newsletter & Stay Updated
